Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Xenopus oocyte germinal-vesicle breakdown induced by [Val12]Ras is inhibited by a cytosol-localized Ras mutant.
Gibbs JB
,
Schaber MD
,
Schofield TL
,
Scolnick EM
,
Sigal IS
.
???displayArticle.abstract???
The GTPase-activating protein (GAP) has been postulated to function either as a negative regulator or as a possible target protein of Ras in mammalian cells and Xenopus oocytes. Ras must be localized in the plasma membrane of vertebrate cells to function, but GAP is localized in the cytosol. To test whether Ras function depends on a cytosolic factor such as GAP, we microinjected into Xenopus oocytes a form of Saccharomyces cerevisiae RAS1 ([Leu68]RAS1 terminated at residue 185, called [Leu68]RAS1(term.] that lacks the consensus membrane localization site, does not respond to GAP in a GTPase assay, but binds to GAP 100-fold more tightly than [Val12]Ras. [Leu68]RAS1(term.) alone did not stimulate oocyte germinal-vesicle breakdown. Instead, [Leu68]RAS1(term.) was observed to inhibit the action of insulin-like growth factor 1 or microinjected [Val12]Ras but not the action of progesterone as monitored by germinal-vesicle breakdown. Coinjection of purified mammalian GAP with [Leu68]RAS1(term.) reduced the inhibition of [Val12]Ras-stimulated germinal-vesicle breakdown. The results raise the possibility that a cytosolic factor is required for the action of [Val12]Ras in Xenopus oocytes and that this factor is either GAP or another protein with which GAP can compete for binding to [Leu68]RAS1(term.).
Adari,
Guanosine triphosphatase activating protein (GAP) interacts with the p21 ras effector binding domain.
1988, Pubmed
Adari,
Guanosine triphosphatase activating protein (GAP) interacts with the p21 ras effector binding domain.
1988,
Pubmed
Barbacid,
ras genes.
1987,
Pubmed
Bayne,
Expression, purification and characterization of recombinant human insulin-like growth factor I in yeast.
1988,
Pubmed
Birchmeier,
ras proteins can induce meiosis in Xenopus oocytes.
1985,
Pubmed
,
Xenbase
Calés,
The cytoplasmic protein GAP is implicated as the target for regulation by the ras gene product.
1988,
Pubmed
Clarke,
Posttranslational modification of the Ha-ras oncogene protein: evidence for a third class of protein carboxyl methyltransferases.
1988,
Pubmed
DeFeo-Jones,
Mammalian and yeast ras gene products: biological function in their heterologous systems.
1985,
Pubmed
Deshpande,
Insulin induction of Xenopus laevis oocyte maturation is inhibited by monoclonal antibody against p21 ras proteins.
1987,
Pubmed
,
Xenbase
Feig,
Inhibition of NIH 3T3 cell proliferation by a mutant ras protein with preferential affinity for GDP.
1988,
Pubmed
Feramisco,
Microinjection of the oncogene form of the human H-ras (T-24) protein results in rapid proliferation of quiescent cells.
1984,
Pubmed
Fujiyama,
Processing and fatty acid acylation of RAS1 and RAS2 proteins in Saccharomyces cerevisiae.
1986,
Pubmed
Gibbs,
Purification of ras GTPase activating protein from bovine brain.
1988,
Pubmed
,
Xenbase
Gibbs,
The ras oncogene--an important regulatory element in lower eucaryotic organisms.
1989,
Pubmed
Gutierrez,
Post-translational processing of p21ras is two-step and involves carboxyl-methylation and carboxy-terminal proteolysis.
1989,
Pubmed
Kitayama,
A ras-related gene with transformation suppressor activity.
1989,
Pubmed
Korn,
Ras p21 as a potential mediator of insulin action in Xenopus oocytes.
1987,
Pubmed
,
Xenbase
Magee,
Dynamic fatty acylation of p21N-ras.
1987,
Pubmed
Marshall,
A C-terminal domain of GAP is sufficient to stimulate ras p21 GTPase activity.
1989,
Pubmed
Powers,
Dominant yeast and mammalian RAS mutants that interfere with the CDC25-dependent activation of wild-type RAS in Saccharomyces cerevisiae.
1989,
Pubmed
Sadler,
A similar pool of cyclic AMP phosphodiesterase in Xenopus oocytes is stimulated by insulin, insulin-like growth factor 1, and [Val12,Thr59]Ha-ras protein.
1989,
Pubmed
,
Xenbase
Sigal,
Structure/function studies of the ras protein.
1988,
Pubmed
Sigal,
Mutant ras-encoded proteins with altered nucleotide binding exert dominant biological effects.
1986,
Pubmed
Stacey,
Transformation of NIH 3T3 cells by microinjection of Ha-ras p21 protein.
,
Pubmed
Tanaka,
IRA1, an inhibitory regulator of the RAS-cyclic AMP pathway in Saccharomyces cerevisiae.
1989,
Pubmed
Temeles,
Expression and characterization of ras mRNAs from Saccharomyces cerevisiae.
1984,
Pubmed
Temeles,
Yeast and mammalian ras proteins have conserved biochemical properties.
,
Pubmed
Trahey,
A cytoplasmic protein stimulates normal N-ras p21 GTPase, but does not affect oncogenic mutants.
1987,
Pubmed
,
Xenbase
Trahey,
Molecular cloning of two types of GAP complementary DNA from human placenta.
1988,
Pubmed
Vogel,
Cloning of bovine GAP and its interaction with oncogenic ras p21.
1988,
Pubmed
Wigler,
Studies of RAS function in the yeast Saccharomyces cerevisiae.
1988,
Pubmed
Willumsen,
Harvey murine sarcoma virus p21 ras protein: biological and biochemical significance of the cysteine nearest the carboxy terminus.
1984,
Pubmed
Willumsen,
The p21 ras C-terminus is required for transformation and membrane association.
,
Pubmed
